These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19401884)

  • 1. Lentivirus-mediated sFlt-1 gene fragment transfer suppresses retinal neovascularization.
    Min Z; Qiang W; Benwen S; Bin L; Xinhua D
    Curr Eye Res; 2009 May; 34(5):401-10. PubMed ID: 19401884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
    McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy.
    Stitt AW; McKenna D; Simpson DA; Gardiner TA; Harriott P; Archer DB; Nelson J
    Am J Pathol; 1998 May; 152(5):1359-65. PubMed ID: 9588904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer.
    Rota R; Riccioni T; Zaccarini M; Lamartina S; Gallo AD; Fusco A; Kovesdi I; Balestrazzi E; Abeni DC; Ali RR; Capogrossi MC
    J Gene Med; 2004 Sep; 6(9):992-1002. PubMed ID: 15352072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
    Elner SG; Elner VM; Yoshida A; Dick RD; Brewer GJ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):299-303. PubMed ID: 15623788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization.
    Suzuma K; Takagi H; Otani A; Suzuma I; Honda Y
    Microvasc Res; 1998 Nov; 56(3):183-91. PubMed ID: 9828156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.
    Bainbridge JW; Mistry A; De Alwis M; Paleolog E; Baker A; Thrasher AJ; Ali RR
    Gene Ther; 2002 Mar; 9(5):320-6. PubMed ID: 11938451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
    Kinose F; Roscilli G; Lamartina S; Anderson KD; Bonelli F; Spence SG; Ciliberto G; Vogt TF; Holder DJ; Toniatti C; Thut CJ
    Mol Vis; 2005 May; 11():366-73. PubMed ID: 15951738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
    Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
    J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys.
    Lai CM; Shen WY; Brankov M; Lai YK; Barnett NL; Lee SY; Yeo IY; Mathur R; Ho JE; Pineda P; Barathi A; Ang CL; Constable IJ; Rakoczy EP
    Mol Ther; 2005 Oct; 12(4):659-68. PubMed ID: 16023893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
    Zhang M; Yang Y; Yan M; Zhang J
    Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
    Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
    Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT
    Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered retinal neovascularization in TNF receptor-deficient mice.
    Ilg RC; Davies MH; Powers MR
    Curr Eye Res; 2005 Nov; 30(11):1003-13. PubMed ID: 16282134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model.
    Igarashi T; Miyake K; Kato K; Watanabe A; Ishizaki M; Ohara K; Shimada T
    Gene Ther; 2003 Feb; 10(3):219-26. PubMed ID: 12571629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector.
    Lai CM; Estcourt MJ; Wikstrom M; Himbeck RP; Barnett NL; Brankov M; Tee LB; Dunlop SA; Degli-Esposti MA; Rakoczy EP
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4279-87. PubMed ID: 19357358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.